Influence of MTHFR C677T Polymorphism on High-Dose Methotrexate-Related Toxicity in Patients With Primary Central Nervous System Diffuse Large B-Cell Lymphoma-Reference-Cited by-同舟云学术

Influence of MTHFR C677T Polymorphism on High-Dose Methotrexate-Related Toxicity in Patients With Primary Central Nervous System Diffuse Large B-Cell Lymphoma

Published:2021-02 Issue:2 Volume:21 Page:91-96
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Chang Xiaoli^ORCID,Guo Yixian,Su Li,Zhang Yunxiu,Hui Wuhan,Zhao Hong,Hu Ronghua,Sun Wanling^ORCID

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference38 articles.

1. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009;Dolecek;Neuro Oncol,2012

2. Primary lymphoma of the central nervous system: epidemiology, pathology and current approaches to diagnosis, prognosis and treatment;Rubenstein;Leuk Lymphoma,2008

3. The challenge of primary CNS lymphoma;Carnevale;Hematol Oncol Clin North Am,2016

4. Managing reduced methotrexate clearance in a patient with a heterozygous methylenetetrahydrofolate reductase gene polymorphism;Gammon;J Oncol Pharm Pract,2008

5. Methotrexate-induced toxicity pharmacogenetics: an umbrella review of systematic reviews and meta-analyses;Campbell;Pharmacogenomics J,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic polymorphisms and clinical parameters associated with renal toxicity in Thai hematologic malignancy patients receiving high dose methotrexate;Scientific Reports;2024-04-27

2. Risk factors associated with high-dose methotrexate induced toxicities;Expert Opinion on Drug Metabolism & Toxicology;2024-03-19

3. Development and validation of a model to predict acute kidney injury following high‐dose methotrexate in patients with lymphoma;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2023-11-14

4. Toxicity associated with high-dose intravenous methotrexate for hematological malignancies;Leukemia & Lymphoma;2022-05-16

5. Medication therapy of high‐dose methotrexate: An evidence‐based practice guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society;British Journal of Clinical Pharmacology;2022-02-08